Company
Robeauté
- Biotech
- Founded:
- 2017
- Location:
- Paris, France
Description
Robeauté develops a brain microrobotic platform for neuro-interventions, using rice-sized microrobots and related infrastructure to better understand and treat brain disease, with design goals spanning treatment, diagnosis, monitoring, and surgery.
Robeauté is located in the Paris ecosystem.
Related
BioArcticBioArctic develops therapeutics and related technologies for neurodegenerative disorders, focusing on disease-modifying treatments and…
ceregateceregate provides a hardware-agnostic computer–brain interface platform that enables new communication channels with the brain to restore…
CARTHERACARTHERA develops SonoCloud, an implanted ultrasound device that emits low-intensity pulsed ultrasound to transiently open the blood–brain…
Anacalypsis TherapeuticsAnacalypsis Therapeutics creates precision gene- and pathway-based therapeutic strategies, biomarkers, and genetically linked targets to…
inbrain-neuroelectronicsinbrain-neuroelectronics develops a graphene-based brain–computer interface that detects high-frequency neural activity with…
BraineverBrainever develops hEN1 and hOTX2 homeoprotein drug candidates intended to limit neurodegenerative disease progression by preventing…
Cumulus NeuroscienceCumulus Neuroscience delivers NeuLogiq for CNS clinical studies, using multimodal digital assessments to monitor discrete brain functions…
- AplagonAplagon develops a therapeutic called APAC, a vascular-injury targeting molecule that combines antiplatelet, anticoagulant, and…
TherapanaceaTherapanacea builds AI software for radiotherapy, offering ART-Plan, an AI application suite for automated segmentation, planning, and…